copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Edwards Lifesciences Corp - Overview Edwards Lifesciences is the leading global structural heart innovation company, driven by a passion to improve patient lives Through breakthrough technologies, world-class evidence and partnerships with clinicians and healthcare stakeholders, our employees are inspired by our patient-focused culture to deliver life-changing innovations to
Newsroom - Edwards Lifesciences Edwards Lifesciences is the leading global structural heart innovation company, driven by a passion to improve patient lives Through breakthrough technologies, world-class evidence and partnerships with clinicians and healthcare stakeholders, our employees are inspired by our patient-focused culture to deliver life-changing innovations to
Our leaders | Edwards Lifesciences Building from Edwards’ foundation rooted in the company’s Credo, the patient-focused culture and the unique innovation strategy, Zovighian and the global Edwards employees are united and inspired to enable the company’s sustainable growth and extend its global leadership
Contact Us | Edwards Lifesciences 5:00am - 4:30pm PST,M-F 800 424 3278 We usually respond within one business day customerservice_us@edwards com
Press Releases | Edwards Lifesciences TRISCEND II SIX-MONTH DATA FOR FIRST 150 PATIENTS SUCCESSFULLY DEMONSTRATE SAFETY AND EFFICACY OF EDWARDS EVOQUE SYSTEM FOR SEVERE TRICUSPID REGURGITATION Read more
Edwards Lifesciences Completes Sale of Critical Care IRVINE, Calif -- (BUSINESS WIRE)-- Edwards Lifesciences (NYSE: EW) has successfully completed the sale of its Critical Care product group to BD (Becton, Dickinson and Company) (NYSE: BDX) for $4 2 billion in an all-cash transaction
Spain - Edwards Lifesciences Edwards Lifesciences Spain is based in the Parque Tecnólogico in Paterna, near Valencia, from where we support core regional and global business operations and help transform patients’ lives
Edwards Lifesciences Completes Sale of Critical Care IRVINE, Calif -- (BUSINESS WIRE)-- Edwards Lifesciences (NYSE: EW) has successfully completed the sale of its Critical Care product group to BD (Becton, Dickinson and Company) (NYSE: BDX) for $4 2 billion in an all-cash transaction